Advanced Manufacturing Capability
Currently Fosun Wanbang holds and controls 10 subsidiaries and has established 6 manufacturing sites across China.
Fosun Wanbang actively improve the quality system to international level.
At present, more than 10 production lines have passed site inspection by overseas health authority and obtained certification, Among which, one sterile injectable production line has passed the EU and US FDA site inspection, and one oral solid preparation production line has passed the US FDA site inspection.
Manufacturing site in Xuzhou, which locates at Yangshan Road in Jinshanqiao Development Zone, passed the full GMP inspection from US FDA.
INVIMA Recertification
Erythropoietin and Pemetrexed Disodium for Injection Production Line
INVIMA Recertification
Production Line of Erythropoietin for Injection, Production Line of Pemetrexed Disodium for Injection
US FDA Site Inspection
Production Line of Crude Heparin Sodium
Kenya Ministry of Health GMP Certification
Production Line of Azithromycin Dispersible Tablets and Glimepiride
PIC/S certification
（Malaysia National Pharmaceutical Control Bureau）
Production Line of Pemetrexed Disodium for Injection
Nigerian Federal MOH GMP Certification
Production Line of Glimepiride Tablets
EU Site Inspection
Production Line of Sterile Lyophilized Preparations
US FDA Site Inspection
Production Line of Oral Solid Dosage Form
Peru Site Inspection
Non-final Sterilization Small Volume Sterile Injections Workshop
US FDA Site Inspection
Vial workshop inspected by USFDA
US FDA Site Inspection
Full GMP Inspection & OSD PAI Inspection
EU Site Inspection
Production Line of Sterile Lyophilized Preparations
US FDA EIR Letter
EU GMP for Injectable Workshop
Years in the healthcare market and with the resources by Fosun Pharma have enabled us to create tight relationships with our partners.
We currently cooperate with partners on a worldwide level that come from over 30 countries.
Our products are currently exported to North America, Europe, South America, South East Asia, and Africa Markets.
We keep providing our value-added portfolio to partners around the globe, combining our strong heritage in diabetes and chronic diseases with a wide offering in other additional therapeutic areas.
Fosun Wanbang is committed to public health, providing in-depth innovative products and professional services in every target therapeutic area, and intended to move health forward for our customers and patients worldwide.
As the international business unit of Fosun Wanbang, we are continuously seeking new partners on a global level.
